https://www.apheris.com 2026-09-10T17:09:09.226Z https://www.apheris.com/networks/aisb 2026-09-10T15:47:18.102Z https://www.apheris.com/networks/admet 2026-09-10T15:47:28.321Z https://www.apheris.com/networks/antibody-developability-consortium 2026-09-10T15:47:18.109Z https://www.apheris.com/networks/federated-real-world-evidence-rwe-network 2026-09-10T09:01:17.652Z https://www.apheris.com/resources 2026-09-09T08:48:09.507Z https://www.apheris.com/about-apheris 2026-09-10T15:52:33.107Z https://www.apheris.com/careers 2026-09-10T17:11:35.786Z https://www.apheris.com/imprint 2026-09-10T09:19:41.866Z https://www.apheris.com/privacy-policy 2026-09-10T10:16:58.651Z https://www.apheris.com/foundry 2026-09-10T16:01:04.556Z https://www.apheris.com/apherisfold 2026-09-10T13:17:44.039Z https://www.apheris.com/contact-us 2026-09-09T08:50:20.364Z https://www.apheris.com/datenschutzbestimmungen 2026-09-09T08:49:44.852Z https://www.apheris.com/admet-summary 2026-09-09T08:52:35.001Z https://www.apheris.com/aisb-case-study 2026-09-09T08:50:57.210Z https://www.apheris.com/docs 2026-09-10T16:36:46.716Z https://www.apheris.com/resources/a-new-operational-standard-for-industrial-federation 2026-09-03T14:15:43.748Z https://www.apheris.com/resources/a-simulated-federated-analysis-of-ms-induced-brain-lesions 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/abbvie-j-and-j-to-add-proprietary-data-to-ai-protein-model-in-bid-to-accelerate-drug-discovery 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/admet-predictions-get-ai-boost-federated-data-network-unites-pharma 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/advancing-protein-prediction-with-federated-learning-on-nvidia-dgx-cloud 2026-09-08T15:35:47.018Z https://www.apheris.com/resources/aggregating-low-rank-adapters-in-federated-fine-tuning 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/ai-for-admetox-predictions-state-of-the-art 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/aisb-network-expands-federated-openfold3-initiative-with-three-new-pharma-contributors 2026-09-10T12:58:51.284Z https://www.apheris.com/resources/alphafold-is-running-out-of-data-so-drug-firms-are-building-their-own-version 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/alquraishi-lab-s-openfold3-to-be-fine-tuned-with-pharma-industry-data-in-a-secure-ai-collaboration 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/apheris-achieves-soc-2-type-i-attestation-reinforcing-our-commitment-to-security 2026-09-08T15:35:47.018Z https://www.apheris.com/resources/apheris-achieves-top-information-security-certification-iso-27001 2026-09-01T07:46:56.863Z https://www.apheris.com/resources/apheris-completes-soc2-type2-attestation 2026-09-01T07:46:56.863Z https://www.apheris.com/resources/apheris-joins-the-global-alliance-for-genomics-health 2026-09-01T07:46:56.863Z https://www.apheris.com/resources/apheris-launches-admet-network 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/apheris-launches-apherisfold-to-make-openfold3-securely-usable-in-pharma-environments 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/apheris-launches-platform-to-unlock-data-and-enable-collaboration 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/apheris-launches-trust-center-elevating-security-and-data-privacy-standards 2026-09-08T15:35:47.018Z https://www.apheris.com/resources/apheris-raises-eu8-7m-to-power-development-of-smarter-ai 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/apheris-rethinks-the-ai-data-bottleneck-in-life-science-with-federated-computing 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/aws-launches-amazon-bio-discovery-to-accelerate-ai-powered-research-in-life-sciences 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/beyond-the-data-volume-assumption-the-role-of-complementary-data-in-admet-modelling 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/bio-it-world-keynote-highlights-collaborative-intelligence-in-ai-driven-drug-discovery 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/building-fine-tuning-capabilities-for-co-folding-models-in-pharmaceutical-research 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/co-folding-models-in-lead-optimization-workflows 2026-09-10T14:53:01.765Z https://www.apheris.com/resources/discover-pharma-aisb-network-expands-federated-openfold3-initiative-with-three-new-pharma-contributors 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/federated-learning-based-protein-language-models-with-apheris-on-aws 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/federated-learning-for-admet-prediction-expanding-model-applicability 2026-09-08T15:35:47.018Z https://www.apheris.com/resources/federated-learning-for-lesion-segmentation-in-multiple-sclerosis-a-real-world-multi-center-feasibility-study 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/fine-tuning-openfold3-on-a-small-set-of-structures-the-pde10-case-study 2026-09-02T10:31:01.963Z https://www.apheris.com/resources/fine-tuning-the-openfold3-affinity-head-on-a-small-jak2-macrocycle-dataset 2026-09-07T08:12:06.487Z https://www.apheris.com/resources/ginkgo-datapoints-and-apheris-launch-antibody-developability-consortium 2026-09-03T12:27:44.681Z https://www.apheris.com/resources/hands-on-with-apherisfold-reproducing-a-sik3-ampk-selectivity-study-using-openfold3 2026-09-10T08:47:13.867Z https://www.apheris.com/resources/how-cisos-can-enable-productization-of-valuable-data-assets 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/insights-into-the-unknown-federated-data-diversity-analysis-on-molecular-data 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/openfold-expands-ai-for-biological-modeling-mission-with-two-new-members 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/protenix-v1-is-now-available-in-apherisfold 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/secure-ai-collaboration-will-fine-tune-openfold3-with-proprietary-data 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/top-7-open-source-frameworks-for-federated-learning 2026-09-01T07:46:56.863Z https://www.apheris.com/resources/toward-a-tipping-point-in-federated-learning-in-healthcare-and-life-sciences 2026-09-03T12:47:03.699Z https://www.apheris.com/resources/when-does-protein-ligand-co-folding-become-useful-in-real-medicinal-chemistry 2026-09-02T10:31:01.963Z https://www.apheris.com/resources/where-admet-models-break-and-why-federation-is-the-right-fix 2026-09-02T10:50:18.494Z https://www.apheris.com/resources/why-co-folding-models-are-here-to-stay 2026-09-08T15:35:47.018Z https://www.apheris.com/author/alwin-otto-bucher 2026-09-03T15:30:37.747Z https://www.apheris.com/author/avelino-javer 2026-09-03T15:30:37.747Z https://www.apheris.com/author/benedict-w-j-irwin 2026-09-03T15:30:37.747Z https://www.apheris.com/author/calum-hand 2026-09-03T15:30:37.747Z https://www.apheris.com/author/ian-hales 2026-09-03T15:30:37.747Z https://www.apheris.com/author/jonathan-cremers 2026-09-03T15:30:37.747Z https://www.apheris.com/author/jose-tomas-jt-prieto 2026-09-03T15:30:37.747Z https://www.apheris.com/author/lewis-mervin 2026-09-03T15:30:37.747Z https://www.apheris.com/author/lukas-pluska 2026-09-03T15:30:37.747Z https://www.apheris.com/author/marie-roehm 2026-09-03T15:30:37.747Z https://www.apheris.com/author/mark-sharpley 2026-09-03T15:30:37.747Z https://www.apheris.com/author/nicolas-gautier 2026-09-03T15:30:37.747Z https://www.apheris.com/author/rosemary-huckvale 2026-09-03T15:30:37.747Z